secwatch / observer
8-K filed July 22, 2026, 4:02 PM ET ticker CRVS CIK 0001626971
leadership confidence high sentiment neutral materiality 0.35

Director Ian T. Clark resigns from Corvus board effective July 22, 2026

Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-26-085790
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.